Literature DB >> 36169687

Apparent diffusion coefficient for assessing Crohn's disease activity: a meta-analysis.

Maximilian Thormann1, Bohdan Melekh2, Caroline Bär2, Maciej Pech2, Jazan Omari2, Andreas Wienke3, Hans-Jonas Meyer4, Alexey Surov2.   

Abstract

PURPOSE: To analyze relationships betweenapparent diffusion coefficient (ADC) and activity parameters of Crohn's disease, e.g., length and wall thickness, CRP, FCP, MaRIA, CDAI, SES-CD, histologic inflammatory activity score, and the histological fibrotic score, based upon published data.
MATERIALS AND METHODS: MEDLINE library, Scopus, and Embase databases were screened for association between ADC and activity parameters of Crohn's disease in patients with Crohn's disease up to Mai 2021. Overall, 21 studies with 1053 patients were identified. The following data were extracted from the literature: number of patients, correlation coefficients between ADC and length as well as wall thickness, CRP, FCP, MaRIA, CDAI, and SES-CD, inflammatory activity score, and fibrotic score. Associations between ADC and activity parameters were analyzed by Spearman's correlation coefficient. The studies' methodologic quality was evaluated by using the Quality Assessment of Diagnostic Studies (QUADAS 2) instrument, revealing a low risk of bias.
RESULTS: In the overall sample, the pooled correlation coefficient between ADC and CDAI was -0.8 (95% CI = [-0.94; -0.65]), between ADC and MaRIA -0.66 (95% CI = [-0.79; -0.53]). A strong association was observed between ADC and SES-CD with a pooled correlation of -0.66 (95% CI = [-0.87; -0.46]). The pooled sensitivity to discriminate between involved and non-involved bowel segments was 0.89, with an area under the curve of 0.89
CONCLUSIONS: ADC showed strong inverse correlations with CDAI, MaRIA, and SES-CD scores. However, the role of ADC in assessing fibrotic changes in the bowel wall is limited. ADC can reflect acute inflammatory reactions but not systemic inflammation. KEY POINTS: • ADC value can reflect acute inflammatory reactions but not systemic inflammation. • ADC is inversely correlated with CDAI, MaRIA, and SES-CD. • The role of ADC in assessing fibrotic changes in the bowel wall is limited.
© 2022. The Author(s).

Entities:  

Keywords:  Crohn’s disease; Diffusion-weighted imaging; Magnetic resonance imaging; Meta-analysis

Year:  2022        PMID: 36169687     DOI: 10.1007/s00330-022-09149-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  24 in total

1.  Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.

Authors:  Xue-Hua Li; Can-Hui Sun; Ren Mao; Si-Yun Huang; Zhong-Wei Zhang; Xu-Feng Yang; Li Huang; Jin-Jiang Lin; Jian Zhang; Shomron Ben-Horin; Shi-Ting Feng; Min-Hu Chen; Zi-Ping Li
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

2.  MR-enterography with diffusion weighted imaging: ADC values in normal and pathological bowel loops, a possible threshold ADC value to differentiate active from inactive Crohn's disease.

Authors:  V Ninivaggi; M Missere; G Restaino; E Gangemi; M Di Matteo; A Pierro; G Sallustio; L Bonomo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-11       Impact factor: 3.507

3.  Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease.

Authors:  Peter C Church; Mary-Louise C Greer; Ruth Cytter-Kuint; Andrea S Doria; Anne M Griffiths; Dan Turner; Thomas D Walters; Brian M Feldman
Journal:  Pediatr Radiol       Date:  2017-03-10

4.  Diffusion-weighted magnetic resonance enterocolonography in assessing Crohn disease activity.

Authors:  Vestina Strakšytė; Gediminas Kiudelis; Irina Gineikienė; Algidas Basevičius; Saulius Lukoševičius; Limas Kupčinskas
Journal:  Pol Arch Intern Med       Date:  2020-07-06

5.  Characterization of Degree of Intestinal Fibrosis in Patients with Crohn Disease by Using Magnetization Transfer MR Imaging.

Authors:  Xue-Hua Li; Ren Mao; Si-Yun Huang; Can-Hui Sun; Qing-Hua Cao; Zhuang-Nian Fang; Zhong-Wei Zhang; Li Huang; Jin-Jiang Lin; Yu-Jun Chen; Jordi Rimola; Florian Rieder; Min-Hu Chen; Shi-Ting Feng; Zi-Ping Li
Journal:  Radiology       Date:  2018-01-19       Impact factor: 11.105

6.  MR Enterography Assessment of Bowel Inflammation Severity in Crohn Disease Using the MR Index of Activity Score: Modifying Roles of DWI and Effects of Contrast Phases.

Authors:  Jin Sil Kim; Hye Young Jang; Seong Ho Park; Kyung-Jo Kim; Kyunghwa Han; Suk-Kyun Yang; Byong Duk Ye; Sang Hyoung Park; Jong Seok Lee; Hyun Jin Kim
Journal:  AJR Am J Roentgenol       Date:  2017-02-22       Impact factor: 3.959

7.  Within-network brain connectivity in Crohn's disease patients with gadolinium deposition in the cerebellum.

Authors:  Carlo A Mallio; Claudia Piervincenzi; Filippo Carducci; Livia Quintiliani; Paul M Parizel; Patrizia Pantano; Carlo C Quattrocchi
Journal:  Neuroradiology       Date:  2020-04-04       Impact factor: 2.804

8.  DWI in Pediatric Small-Bowel Crohn Disease: Are Apparent Diffusion Coefficients Surrogates for Disease Activity in Patients Receiving Infliximab Therapy?

Authors:  Jonathan R Dillman; Ethan A Smith; Ramon Sanchez; Jeremy Adler; Soudabeh Fazeli; Bin Zhang; Matthew S Davenport
Journal:  AJR Am J Roentgenol       Date:  2016-08-09       Impact factor: 3.959

9.  Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility.

Authors:  Hao Yu; Ya-Qi Shen; Fang-Qin Tan; Zi-Ling Zhou; Zhen Li; Dao-Yu Hu; John N Morelli
Journal:  World J Gastroenterol       Date:  2019-07-21       Impact factor: 5.742

10.  Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.

Authors:  Yin-Chen Wu; Ze-Bin Xiao; Xue-Hua Lin; Xian-Ying Zheng; Dai-Rong Cao; Zhong-Shuai Zhang
Journal:  World J Gastroenterol       Date:  2020-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.